Sök artiklar i SveMed+

Observera: SveMed+ upphör att uppdateras!



The Perceive, Recall, Plan and Perform (PRPP) system for persons with Parkinson’s disease: a psychometric study
Engelsk titel: The Perceive, Recall, Plan and Perform (PRPP) system for persons with Parkinson’s disease: a psychometric study Läs online Författare: Van Keulen-Rouweler, Bianca J ; Sturkenboom, Ingrid H W M ; Kottorp, Anders ; Graff, Maud J L ; Nijhuis-Van Der Sanden, Maria W G M ; Steultjens, Esther M J Språk: Eng Antal referenser: 36 Dokumenttyp: Artikel UI-nummer: 17020182

Tidskrift

Scandinavian Journal of Occupational Therapy 2017;24(1)65-73 ISSN 1103-8128 E-ISSN 1651-2014 KIBs bestånd av denna tidskrift Denna tidskrift är expertgranskad (Peer-Reviewed)

Sammanfattning

Background: The Perceive, Recall, Plan & Perform (PRPP) system of task analysis might be feasible to evaluate occupational performance and information processing strategies for persons with Parkinson’s disease (PD). Aim: To evaluate: (1) the random error between raters (inter-rater study), (2) the random error within raters (intra-rater study), and (3) the internal consistency of the PRPP. Materials and methods: (1) video-recorded performance of meaningful activities of 13 Dutch persons with PD, scored independently by 38 Dutch PRPP trained occupational therapists were included in the analysis. The random error between raters was analyzed with two-way random Intraclass Correlation Coefficients (ICC). (2) Four videos were scored twice by 30 raters (6 week time interval). The random error within raters was analyzed using one-way random ICC’s. (3) Internal consistency study: data of 190 persons with PD were analyzed using Cronbach’s alpha (a). Results: Inter-rater reliability ranged from slight to moderate (ICC¼ 0.06–0.43). The mean intrarater reliability ranged from moderate to almost perfect (ICC¼ 0.60–0.83). Internal consistency is good (a ¼ 0.60–0.86). Conclusion: The limited inter-rater reliability but adequate intra-rater reliability and internal consistency show the feasibility of the PRPP when used for persons with PD. Implications for reliable clinical use are discussed.